RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

Daiichi Sankyo Co ROCE 2024

Daiichi Sankyo Co ROCE

0.08

Daiichi Sankyo Co Dividend yield

Ticker

4568.T

ISIN

JP3475350009

WKN

A0F57T

In 2024, Daiichi Sankyo Co's return on capital employed (ROCE) was 0.08, a 54.27% increase from the 0.05 ROCE in the previous year.

Daiichi Sankyo Co Aktienanalyse

What does Daiichi Sankyo Co do?

Daiichi Sankyo Co Ltd is a company specialized in the production of medicines. The company was founded in 2005 and was formed from the merger of two Japanese pharmaceutical companies. However, the history of Daiichi Sankyo dates back to 1899 when the Daiichi Group and Sankyo Renkyu merged to form a cooperative. Both companies had been active in the pharmaceutical business since the 1960s and were specialized in the development and production of drugs. Daiichi Sankyo's business model is focused on developing and globally marketing innovative drugs. The company focuses on researching and marketing drugs for the treatment of cancer, cardiovascular diseases, and infectious diseases. Daiichi Sankyo is divided into different divisions. The pharmaceutical division is the company's most important business segment. Here, drugs for various applications are developed and produced, including medications for the therapy of cancer, cardiovascular diseases, and infections. Another division is the medical devices division. Here, medical devices such as catheters and stents for the treatment of cardiovascular diseases, as well as endoscopic devices for the diagnosis and therapy of gastrointestinal diseases, are manufactured. Another important area is the diagnostics division. Here, diagnostic test systems for various applications are developed and manufactured. Some of Daiichi Sankyo's best-known products include the cancer drug Trastuzumab Emtansin and the anticoagulant drug Prasugrel. Daiichi Sankyo is a globally operating company headquartered in Tokyo, Japan. In addition, the company has branches in North, Central, and South America, Europe, Asia, and Oceania. The company places great importance on research and development and participates in numerous collaborations and partnerships with universities and other companies. The goal is to constantly develop new groundbreaking drugs and contribute to the improvement of disease treatment. Overall, Daiichi Sankyo employs approximately 15,000 people worldwide and generates an annual revenue of around 8 billion euros. The company is thus one of the leading companies in the pharmaceutical and medical technology industry and will remain an important player in the global healthcare market in the future. Daiichi Sankyo Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Daiichi Sankyo Co's Return on Capital Employed (ROCE)

Daiichi Sankyo Co's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Daiichi Sankyo Co's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Daiichi Sankyo Co's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Daiichi Sankyo Co’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Daiichi Sankyo Co Stock

What is the ROCE (Return on Capital Employed) of Daiichi Sankyo Co this year?

The ROCE of Daiichi Sankyo Co is 0.08 undefined this year.

How has the ROCE (Return on Capital Employed) of Daiichi Sankyo Co developed compared to the previous year?

The ROCE of Daiichi Sankyo Co has increased by 54.27% increased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Daiichi Sankyo Co?

A high Return on Capital Employed (ROCE) indicates that Daiichi Sankyo Co has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Daiichi Sankyo Co?

A low ROCE (Return on Capital Employed) can indicate that Daiichi Sankyo Co has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Daiichi Sankyo Co impact the company?

An increase in the ROCE of Daiichi Sankyo Co can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Daiichi Sankyo Co affect the company?

A decrease in ROCE of Daiichi Sankyo Co can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Daiichi Sankyo Co?

Some factors that can affect Daiichi Sankyo Co's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Daiichi Sankyo Co so important for investors?

The ROCE of Daiichi Sankyo Co is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Daiichi Sankyo Co take to improve the ROCE?

To improve the ROCE, Daiichi Sankyo Co can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Daiichi Sankyo Co pay?

Over the past 12 months, Daiichi Sankyo Co paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Daiichi Sankyo Co is expected to pay a dividend of 35.49 JPY.

What is the dividend yield of Daiichi Sankyo Co?

The current dividend yield of Daiichi Sankyo Co is .

When does Daiichi Sankyo Co pay dividends?

Daiichi Sankyo Co pays a quarterly dividend. This is distributed in the months of October, April, October, April.

How secure is the dividend of Daiichi Sankyo Co?

Daiichi Sankyo Co paid dividends every year for the past 22 years.

What is the dividend of Daiichi Sankyo Co?

For the upcoming 12 months, dividends amounting to 35.49 JPY are expected. This corresponds to a dividend yield of 0.71 %.

In which sector is Daiichi Sankyo Co located?

Daiichi Sankyo Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Daiichi Sankyo Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Daiichi Sankyo Co from 6/1/2024 amounting to 30 JPY, you needed to have the stock in your portfolio before the ex-date on 3/28/2024.

When did Daiichi Sankyo Co pay the last dividend?

The last dividend was paid out on 6/1/2024.

What was the dividend of Daiichi Sankyo Co in the year 2023?

In the year 2023, Daiichi Sankyo Co distributed 28.5 JPY as dividends.

In which currency does Daiichi Sankyo Co pay out the dividend?

The dividends of Daiichi Sankyo Co are distributed in JPY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Daiichi Sankyo Co stock can be added to a savings plan with the following providers: Consorsbank

Andere Kennzahlen von Daiichi Sankyo Co

Our stock analysis for Daiichi Sankyo Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Daiichi Sankyo Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.